STOCK TITAN

Eupraxia Pharmaceuticals (EPRX) holders report around 4–5% stakes in 13G/A

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Manchester Management Company, LLC, Manchester Management PR, LLC, Manchester Explorer, L.P., James E. Besser, and Morgan C. Frank report their ownership of common shares of Eupraxia Pharmaceuticals Inc. on an amended Schedule 13G (Amendment No. 3).

Reported beneficial ownership includes 2,634,048 shares (4.3% of the class) for each of Manchester Management Company, LLC and Manchester Management PR, LLC, 2,511,121 shares (4.1%) for Manchester Explorer, L.P., 2,772,341 shares (4.5%) for James E. Besser, and 2,664,780 shares (4.3%) for Morgan C. Frank. Besser has sole voting and dispositive power over 138,293 shares and Frank over 153,659 shares, with the remainder held under shared voting and dispositive power.

The filing states that, other than the shares over which Besser and Frank have sole power, all reported securities are directly owned by advisory clients of Manchester Management PR, LLC and that none of these advisory clients may be deemed to beneficially own more than 5% of Eupraxia’s common shares. Each reporting person disclaims beneficial ownership beyond their pecuniary interest.

Positive

  • None.

Negative

  • None.
Shares owned - Manchester Management Company, LLC 2,634,048 shares Beneficially owned; 4.3% of Eupraxia common shares
Shares owned - Manchester Management PR, LLC 2,634,048 shares Beneficially owned; 4.3% of Eupraxia common shares
Shares owned - Manchester Explorer, L.P. 2,511,121 shares Beneficially owned; 4.1% of Eupraxia common shares
Shares owned - James E. Besser 2,772,341 shares Beneficially owned; 4.5% of Eupraxia common shares
Shares owned - Morgan C. Frank 2,664,780 shares Beneficially owned; 4.3% of Eupraxia common shares
Besser sole voting power 138,293 shares Shares over which James E. Besser has sole voting and dispositive power
Frank sole voting power 153,659 shares Shares over which Morgan C. Frank has sole voting and dispositive power
beneficially owned financial
"Amount beneficially owned: MANCHESTER MANAGEMENT COMPANY, LLC - 2,634,048"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared power to vote financial
"Shared power to vote or to direct the vote: 2,634,048"
shared dispositive power financial
"Shared power to dispose or to direct the disposition of: 2,634,048"
pecuniary interest financial
"disclaims beneficial ownership ... except to the extent of his, her or its pecuniary interest"
Investment Company Act of 1940 regulatory
"A listing of the shareholders of an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

What ownership in EUPRAXIA PHARMACEUTICALS INC. (EPRX) is reported by Manchester Management entities?

Manchester Management Company, LLC and Manchester Management PR, LLC each report 2,634,048 common shares of Eupraxia Pharmaceuticals Inc., representing 4.3% of the outstanding class, with shared voting and dispositive power over those shares.

How many EPRX shares does Manchester Explorer, L.P. beneficially own?

Manchester Explorer, L.P. reports beneficial ownership of 2,511,121 Eupraxia common shares, equal to 4.1% of the class, all held with shared power to vote and dispose, and no sole voting or dispositive power over these shares.

What are James E. Besser’s reported holdings in EUPRAXIA PHARMACEUTICALS INC. (EPRX)?

James E. Besser reports beneficial ownership of 2,772,341 Eupraxia common shares, or 4.5% of the class, including 138,293 shares over which he has sole voting and dispositive power and 2,634,048 shares subject to shared powers.

What are Morgan C. Frank’s reported holdings in EUPRAXIA PHARMACEUTICALS INC. (EPRX)?

Morgan C. Frank reports beneficial ownership of 2,664,780 Eupraxia common shares, representing 4.3% of the class, including 153,659 shares with sole voting and dispositive power and 2,511,121 shares with shared voting and dispositive power.

Do Manchester Management PR, LLC’s advisory clients individually hold more than 5% of EPRX?

The filing states that all reported securities, other than those over which Besser and Frank have sole power, are owned by advisory clients of Manchester Management PR, LLC and that none of these clients may be deemed to beneficially own more than 5% of the common shares.

What does the Schedule 13G/A say about beneficial ownership disclaimers for EPRX?

Each reporting person disclaims beneficial ownership of the reported Eupraxia securities except to the extent of their pecuniary interest, and the report states it should not be deemed an admission of beneficial ownership for Section 16 or any other purpose.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





29842P105

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



MANCHESTER MANAGEMENT COMPANY, LLC
Signature:/s/ James E. Besser
Name/Title:James E. Besser, Managing Member
Date:08/13/2026
MANCHESTER MANAGEMENT PR, LLC
Signature:/s/ James E. Besser
Name/Title:James E. Besser, Managing Member
Date:08/13/2026
MANCHESTER EXPLORER, L.P.
Signature:/s/ James E. Besser
Name/Title:James E. Besser, Managing Member of the General Partner
Date:08/13/2026
JAMES E. BESSER
Signature:/s/ James E. Besser
Name/Title:James E. Besser
Date:08/13/2026
MORGAN C. FRANK
Signature:/s/ Morgan C. Frank
Name/Title:Morgan C. Frank
Date:08/13/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement